Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome

Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome

Elevated LDL-cholesterol (LDL-C) plays a major role in atheroma formation and inflammation. Medical therapy to lower elevated LDL-C is the cornerstone for reducing the progression of atherosclerotic cardiovascular disease. Statin therapy, and more recently, other drugs such as proprotein convertase...

Full description

Bibliographic Details
Main Authors: F. B. Mensink, J. Los, T. J. F. Ten Cate, R. M. Oemrawsingh, M. A. Brouwer, S. El Messaoudi, N. van Royen, J. H. Cornel, N. P. Riksen, R. J. M. van Geuns
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
ACS
PCSK9 inhibition therapy
MACE
statins
LDL-C
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1061346/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1061346/full

Similar Items